Literature DB >> 3122547

Echocardiographic abnormalities in the mucopolysaccharide storage diseases.

D M Gross1, J C Williams, C Caprioli, B Dominguez, R R Howell.   

Abstract

The mucopolysaccharide storage diseases express themselves clinically with a wide variety of abnormalities, including growth and mental retardation, skeletal abnormalities, clouded corneas, nerve compression syndromes, upper airway obstruction and cardiovascular involvement, to name the most common. In most cases the cause of early death is cardiorespiratory failure secondary to cardiovascular involvement and upper airway obstruction. The findings of cardiac ultrasound examination in 29 children, adolescents and young adults are presented. In addition to the previously well-described abnormalities of the mitral and aortic valves in several types of mucopolysaccharide storage disease, we report patchy involvement in some cases, 3 instances of asymmetric septal hypertrophy not previously reported in mucopolysaccharide storage diseases, cardiac involvement in half of our patients with Sanfilippo syndrome and a lack of age-related severity of cardiac involvement even within the specific syndromes.

Entities:  

Mesh:

Year:  1988        PMID: 3122547     DOI: 10.1016/0002-9149(88)91325-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

1.  Natural history of echocardiographic abnormalities in mucopolysaccharidosis III.

Authors:  Carolyn M Wilhelm; Kristen V Truxal; Kim L McBride; John P Kovalchin; Kevin M Flanigan
Journal:  Mol Genet Metab       Date:  2018-04-27       Impact factor: 4.797

2.  Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.

Authors:  L Schroeder; P Orchard; C B Whitley; J M Berry; J Tolar; W Miller; E A Braunlin
Journal:  JIMD Rep       Date:  2013-02-12

3.  Left ventricular outflow tract obstruction as a consequence of Sanfilippo's disease.

Authors:  J de Geest; L Cozijnsen; C E Essed; B P M van Nesselrooij
Journal:  Neth Heart J       Date:  2002-10       Impact factor: 2.380

4.  Echocardiographic abnormalities in type IV mucopolysaccharidosis.

Authors:  R M John; D Hunter; R H Swanton
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Congenital polyvalvular disease in trisomy 18: echocardiographic diagnosis.

Authors:  S M Balderston; E M Shaffer; R L Washington; H M Sondheimer
Journal:  Pediatr Cardiol       Date:  1990-07       Impact factor: 1.655

6.  Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.

Authors:  Daniel H Wiseman; Jean Mercer; Karen Tylee; Nilima Malaiya; Denise K Bonney; Simon A Jones; J Edmond Wraith; Robert F Wynn
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

7.  Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation.

Authors:  X Viñallonga; N Sanz; A Balaguer; L Miro; J J Ortega; J Casaldaliga
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

8.  Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome).

Authors:  J Muenzer; R H Beekman; L M Profera; E L Bove
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

9.  Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses.

Authors:  C F Wippermann; M Beck; D Schranz; R Huth; I Michel-Behnke; B K Jüngst
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

10.  Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.

Authors:  Christoph Kampmann; Christina Lampe; Catharina Whybra-Trümpler; Christiane M Wiethoff; Eugen Mengel; Laila Arash; Michael Beck; Elke Miebach
Journal:  J Inherit Metab Dis       Date:  2013-09-24       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.